September 10, 2025

Prenatal Acetaminophen and ADHD/ASD: Linked?

Review of 46 human studies links prenatal acetaminophen to higher ADHD/ASD risk; evidence is heterogeneous; cohort effect sizes are generally modest but larger in some biomarker studies; authors advise cautious, short‑term use under medical guidance.

Conexiant

September 05, 2025

Is Prenatal Chlorpyrifos Exposure Linked to Brain Changes?

Prenatal chlorpyrifos associated with magnetic resonance imaging changes, hypoperfusion, and motor slowing—without age/sex moderation, mediation, or connectivity effects.

Conexiant

September 04, 2025

'No Standard of Care' for GLP-1 Weaning

Without a defined standard of care for tapering GLP-1 medications, physicians must navigate patient management amid insurer restrictions and high discontinuation rates

KFF Health News

September 03, 2025

Fast ADHD Prescribing Seen in Young Kids

How quickly are ADHD meds started in preschool primary care?

Conexiant

September 03, 2025

Policy Shift Adjusts NIH Peer Review Role

New NIH funding rules shift decision-making power from peer review panels to political appointees in determining future scientific grants.

KFF Health News

August 27, 2025

Remission Patterns in Youth at Risk for Psychosis

When participants had at least 1 follow-up visit after achieving remission, the likelihood of staying in remission increased. 

Conexiant

August 27, 2025

Medical Oddities: Is Smoking Good for the Gut?

From ulcerative colitis’ smoky paradox to protein power, boba belly, hair-friendly diets, and sibling rivalries.

Conexiant

August 25, 2025

Baricitinib Aids Eyebrow, Eyelash Regrowth in Alopecia Areata

This study highlights baricitinib’s effectiveness in promoting eyebrow and eyelash regrowth in patients with alopecia areata across two phase III clinical trials.

Conexiant

August 22, 2025

Nemolizumab Study Tracks 68 Weeks of Relief

A long-term clinical study finds that the biologic therapy nemolizumab, when used with topical corticosteroids, continues to improve itch, sleep, and skin symptoms in prurigo nodularis patients over 68 weeks.

Conexiant